Arena Pharmaceuticals Stock News

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction. Foghorn Therapeutics Inc. (NASDAQ: FHTX ) shares jumped 55% to close at $18.58. Loxo Oncology, an R&D group of Eli Lilly And Co (NYSE: LLY ), and Foghorn Therapeutics collaborated to create oncology medicines by applying Foghorn''s Gene Traffic Control platform. BELLUS Health Inc. (NASDAQ: BLU ) gained 48.2% to settle at $8.30 after the company announced topline data its Phase 2b SOOTHE trial of BLU-5937 in Refractory Chronic Cough. Petros Pharmaceuticals, Inc. (NASDAQ: PTPI ) surged 47.4% to close at $3.98 after gaining more than 14% on Friday. Energy Focus, Inc. (NASDAQ: EFOI ) gained 36.2% to close at $4.70. East Stone Acquisition Corporation (NASDAQ: ESSC ) jumped 31.4% to close at $18.40 after gaining over 8% on Friday. Puxin Limited (NYSE: NEW ) climbed 27.1% to settle at $0.41 after tumbling over 10% on Friday.

Pfizer Inc's (NYSE:PFE) agreed acquisition of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) for almost double the closing price of the stock in the previous trading sessions, is just the latest case of

A healthcare titan wants to acquire the drug developer for nearly $7 billion.

A healthcare titan wants to acquire the drug developer for nearly $7 billion.

The ASX is set to follow US sharemarkets lower after stocks tumbled on Monday as traders weighed the potential impacts of less generous monetary policy settings amid Omicron Covid-19 challenges and lofty equity valuations. Shares of Tesla were down 5% with Apple (-2.1%) shares whipsawing as it approached a US$3 trillion market value. Travel companies Carnival (-4.9%) and United Airlines (-5.2%) sold-off. But Pfizer shares rose 4.6% as it agreed to acquire Arena Pharmaceuticals (+80.4%) for US$6.7 billion. Moderna''s shares lifted 5.8% on a White House push for Covid-19 booster shots. At the close of trade, the Dow Jones index fell by 320 points or 0.9% after being down by 361 points earlier in the session. The S&P 500 index dipped by 0.9%, down from a record, with the Nasdaq index lower by 217 points or 1.4%.

Pfizer Inc (NYSE: PFE) executed a definitive agreement with Arena Pharmaceuticals (Nasdaq: ARNA), under which Pfizer Inc will acquire Arena Pharmaceutical for a total equity value of around $6.7 billion. Arena went up 90% after this announcement. Arena Pharmaceuticals is a clinical-stage company that focuses on developing therapies for treating immune-inflammatory diseases. Both companies’ board unanimously approved […] The post Arena Pharmaceuticals up 90% after acquisition announcement appeared first on Invezz .

In todays recent session, 6.21 million shares of the Arena Pharmaceuticals Inc. (NASDAQ:ARNA) have been traded, and its beta is 0.38. Most recently the companys share price was $91.85, and it changed around $41.91 or 83.92% from the last close, which brings the market valuation of the company to $3.29B. ARNA at last check was Arena Pharmaceuticals Inc. (NASDAQ: ARNA): Stock Forecast For 2021 Still Looks Weak With A -30.65% Decline Read More »

A healthcare titan wants to acquire the drug developer for nearly $7 billion.

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) is entering the cannabis space via the $6.7 billion acquisition of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA). The two publicly-traded companies confirm

Pharma giant Pfizer announced on Monday that it''s buying Arena Pharmaceuticals, a drug company that specializes in inflammation and immunology, for almost $7 billion.

Pfizer made headlines on Monday when it announced that it''s buying Arena Pharmaceuticals in $6.7 billion deal. Here are the biggest pharma deals in history.

Pfizer Inc (NYSE: PFE) executed a definitive agreement with Arena Pharmaceuticals (Nasdaq: ARNA), under which Pfizer Inc will acquire Arena Pharmaceutical for a total equity value of around $6.7 bi